Episode Details
Back to Episodes
Episode 220: ASCO GU 2023: Discussing PARPi for CRPC with Michael Morris, MD
Season 2
Episode 220
Published 3 years, 8 months ago
Description
The Uromigos met with Michael Morris, MD while at the 2023 ASCO GU Cancers Symposium to discuss PARP inhibition for castration-resistant prostate cancer and the differing opinions on how and when it should be utilized. Dr. Morris is a prostate cancer specialist and researcher, and the Prostate Cancer Section Head at Memorial Sloan Kettering Cancer Center.